Skip to main content

Your search for “Immune System” returned 447 results

Parsing the Genetic Drivers of Head and Neck Cancers

November 17, 2022

UC San Diego researchers expand and deepen understanding of how genetic aberrations fuel human papilloma virus-negative head and neck cancers and, potentially, provide paths to further refinement and improvement of immune checkpoint inhibitors for HPV-negative head and neck cancers.

CAR Trials Drive Leukemia and Lymphoma Treatment in New Direction

February 23, 2016

…boosting the body’s own immune system to vanquish malignancies. It is among the fastest growing areas of oncology research. Researchers at UC San Diego Moores Cancer Center have launched three clinical trials to test the safety and efficacy of a novel cellular-immunotherapy that uses modified T cells – one of…

Twist on CRISPR Gene Editing Treats Adult-Onset Muscular Dystrophy in Mice

September 14, 2020

UC San Diego researchers demonstrate that one dose of their version of CRISR gene editing can chew up toxic RNA and almost completely reverse symptoms in a mouse model of myotonic dystrophy, a type of adult-onset muscular dystrophy.

Cetuximab Outperforms Durvalumab in Treatment of Head and Neck Cancers

November 19, 2024

The standard treatment for head and neck cancer, cisplatin, can’t be given to some patients due to pre-existing conditions. A new study compares the efficacy of two alternatives: cetuximab, a monoclonal antibody, and durvalumab, an immune checkpoint inhibitor.

Biologists Create Malaria-Blocking Mosquitoes

November 23, 2015

Using a groundbreaking gene editing technique, biologists at UC San Diego, working in collaboration with biologists at UC Irvine, have created a strain of mosquitoes capable of rapidly introducing malaria-blocking genes into a mosquito population through its progeny, ultimately eliminating the insects’ ability to transmit the disease to humans.

Zika Virus May Cause Microcephaly by Hijacking Human Immune Molecule

May 6, 2016

For the first time, researchers at University of California San Diego School of Medicine have determined one way Zika virus infection can damage developing brain cells. The study, published May 6 in Cell Stem Cell, also shows that inhibiting this mechanism reduces brain cell damage, hinting at a new therapeutic…

Medtech Meets Cleantech: Malaria Vaccine Candidate Produced from Algae

February 18, 2015

…malaria parasite protein. The algae-produced protein, paired with an immune-boosting cocktail suitable for use in humans, generated antibodies in mice that nearly eliminated mosquito infection by the malaria parasite. The method is the newest attempt to develop a vaccine that prevents transmission of the malaria parasite from host to mosquito.

Discovery May Shed Light on Why Some HIV-Positive Patients Have More Virus

September 23, 2012

Biologists at UC San Diego have unraveled the anti-viral mechanism of a human gene that may explain why some people infected with HIV have much higher amounts of virus in their bloodstreams than others. Their finding could shed light on the mystery of why some people with HIV never develop…

Peptide Improves Glucose and Insulin Sensitivity, Lowers Weight in Mice

February 7, 2018

Treating obese mice with catestatin (CST), a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of California San Diego School of Medicine researchers.

Common Antibiotic May Be the Answer to Many Multidrug-Resistant Bacterial Infections

June 10, 2015

Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences report that the common antibiotic azithromycin kills many multidrug-resistant bacteria very effectively — when tested under conditions that closely resemble the human body and its natural antimicrobial factors. The researchers believe the…

Category navigation with Social links